Spyre Therapeutics Inc (SYRE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Spyre Therapeutics Inc-Aktie (SYRE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	8.77% 41.64	45.64	57.17	56.89	41.94
Operating Income/Loss	8.77% -41.64	-45.64	-57.17	-56.89	-41.94
Nonoperating Income/Loss	123.28% 5.439	-23.36	-5.358	45.70	5.218
Income/Loss From Continuing Operations Before Tax	47.54% -36.20	-69.00	-62.53	-11.18	-36.72
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	47.54% -36.20	-69.00	-62.53	-11.18	-36.72

ABVX

$88.13

4.60%

IONS

$42.94

2.67%

ARWR

$55.90

4.44%

PRAX

$241.76

2.61%

AXSM

$157.14

2.87%

TGTX

$53.97

3.62%